Stanford University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).

1,744 total trials 264 currently recruiting 1122 completed early-phase tilt top decile by trial count

Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.

Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.

Top-decile sponsor footprint

Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,744 total, page 17 of 35

COMPLETED NA

Accelerated Intermittent Theta Burst Stimulation for Depressive Symptoms

NCT03601117

COMPLETED

Stanford Cardiac Invasive Electrophysiology Novel Computer Experience

NCT03549806

COMPLETED NA

Pain Control for Anterior Cruciate Ligament Reconstruction Patients With Adductor Canal or Femoral Perineural Infusions

NCT03208478

COMPLETED NA

Technology-Based Distractions During Minor Procedures

NCT03628989

COMPLETED NA

Topography-guided LASIK Surgery

NCT03292419

COMPLETED NA

Fruit and Vegetable Vouchers With and Without an SSB Tax

NCT03567967

COMPLETED NA

Effects of Physical Activity Adequacy Mindsets on Health and Wellbeing

NCT03939572

COMPLETED NA

The AMOR Method: Resilience Training for Parents of Children With Autism

NCT03513419

TERMINATED NA

Increasing Use of Continuous Glucose Monitors in Publicly-insured Youth With Type 1 Diabetes

NCT03297762

COMPLETED

A Light Emitting Diode (LED) Mattress for Phototherapy of Jaundiced Newborns

NCT03723005

COMPLETED Phase 4

Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)

NCT03471624

TERMINATED NA

Activity Therapy After Kidney Transplant

NCT03426280

COMPLETED NA

Computerized Training for Individuals Diagnosed With Obsessive-Compulsive and Related Disorders

NCT03182075

TERMINATED NA

Virtual Reality for Enhancement of Vision

NCT07071129

COMPLETED NA

Exercise is Medicine for Patients With CKD

NCT03311763

COMPLETED NA

Accelerated Theta Burst in Treatment-Resistant Depression: A Dose Finding and Biomarker Study

NCT03680781

COMPLETED Phase 2

Exploring Nitrous Oxide Effects for Post Traumatic Stress Disorder (PTSD)

NCT03375294

COMPLETED Phase 3

The Effect of Micro Fragmented Adipose Tissue (MFAT) on Knee Osteoarthritis

NCT03467919

COMPLETED Phase 4

Gastric Acid Suppression and Probiotic Colonization

NCT03327051

COMPLETED Phase 1

On Demand Contraception: Ulipristal Acetate Plus a COX-2 Inhibitor at Peak Fertility

NCT03354117

TERMINATED NA

Corneal Neurotization as a Treatment for Neurotrophic Keratopathy

NCT05809245

COMPLETED Phase 1

The Safety and Tolerability of Pirfenidone for BOS After HCT

NCT03315741

COMPLETED

Assessing the Diagnostic Accuracy of an On-line Questionnaire for Diagnosis of Primary Headache Disorders

NCT03304886

COMPLETED NA

Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Use in Pediatric Procedures

NCT03430206

COMPLETED Phase 2

Intranasal Vasopressin Treatment in Children With Autism

NCT03204786

TERMINATED Phase 2

Fexofenadine Use in Gastroesophageal Reflux Symptoms

NCT03425097

COMPLETED

Evaluating a Personalized Trans-Diagnostic Group Therapy for Anxiety

NCT03457922

COMPLETED NA

Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Control During First Trimester Abortion

NCT03187002

COMPLETED NA

Gait Modification Treatments for Knee Pathology

NCT03116230

TERMINATED NA

Using the Neuroscience of Fear Extinction for Anxiety Reduction

NCT03465137

COMPLETED Phase 4

Effect of Fosaprepitant on Motor Evoked and Somatosensory Evoked Potentials Under General Anesthesia

NCT03197064

COMPLETED NA

Applying Novel Technologies and Methods to Inform the Ontology of Self-Regulation: Binge Eating and Smoking

NCT03353649

COMPLETED Phase 2

Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors

NCT03367923

TERMINATED NA

Intermittent Theta Burst for the Treatment of Alcohol Use Disorders in Veterans

NCT03291431

COMPLETED Early Phase 1

Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT

NCT03183570

COMPLETED NA

Supporting Parents of Young Children With Type 1 Diabetes in Closed-Loop System

NCT03354286

COMPLETED NA

The Influence of Multi-domain Cognitive Training on Large-scale Structural and Functional Brain Networks in MCI

NCT03883308

COMPLETED

Assessment of Pain in Newborns and Older Infants (Infant Pain Assessment Study =

NCT03330496

COMPLETED NA

Leveraging Clinic to Promote Literacy in Young Children

NCT04752943

COMPLETED NA

VR Usage in Non-Invasive Surgical Sub-Specialty Procedures

NCT03464955

COMPLETED

Emotion Regulation in Binge Eating and Purging Among Adolescents

NCT03429114

COMPLETED NA

The Oakland Men's Health Disparities Study

NCT03481270

COMPLETED NA

Hypnosis for Symptom Management in Elective Orthopedic Surgery

NCT03308071

COMPLETED Phase 1

Effects of Aging on Primary and Secondary Vaccine Responses

NCT03312699

COMPLETED NA

Citizen Science to Promote Sustained Physical Activity in Low-Income Communities

NCT03041415

COMPLETED NA

Probiotic Supplement and Microbiome, Immune System and Metabolic Syndrome

NCT03201068

COMPLETED NA

Women's Health Initiative Silent Atrial Fibrillation Recording Study

NCT05366803

COMPLETED NA

Online Automated Self-Hypnosis Program

NCT03931772

COMPLETED NA

Adaptive Treatment for Adolescent Anorexia Nervosa

NCT03097874

TERMINATED

Eye Movement Testing for Diagnosing Encephalopathy in Patients With Liver Disease

NCT04940416

← Previous Page 17 of 35 Next →

Phase Distribution

PhaseTrial count
Phase 1 193
Phase 2 209
Phase 3 51
Phase 4 86

What is open in the Stanford University pipeline

264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).

Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).

Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.